NLS Pharmaceutics News

NLS Pharmaceutics | D: Filing D

Apr 4 04:04

NLS Pharmaceutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.

Mar 28 07:40

NLS Pharmaceutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-YA II PN, Ltd.(9.99%),YA Global Investments II (U.S.), LP(9.99%), etc.

Feb 13 05:41

NLS Pharmaceutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Felix Grisard(9.99%)

Feb 24, 2023 20:55

NLS Pharmaceutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Magnetic Rock Investment AG(8.77%),Ronald Hafner(4.99%)

Feb 15, 2023 05:32

NLS Pharmaceutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eric Konofal(3.2%)

Feb 14, 2023 08:32

NLS Pharmaceutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alexander Zwyer(3.9%)

Feb 14, 2023 05:02

NLS Pharmaceutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-YA II PN, Ltd.(9.99%),YA Global Investments II (U.S.), LP(9.99%), etc.

Jan 4, 2023 04:58

NLS Pharmaceutics | D: Filing D

Dec 22, 2022 05:01

NLS Pharmaceutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(19.99%),BVF Inc.(19.99%), etc.

Dec 17, 2022 05:45

NLS Pharmaceutics | D: Filing D

Oct 14, 2022 18:07

NLS Pharmaceutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 24, 2022 19:06

NLS Pharmaceutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ronald Hafner(20%),Magnetic Rock Investment AG(17.5%)

Feb 19, 2022 06:30

NLS Pharmaceutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Alexander Zwyer(7.4%)

Feb 14, 2022 21:03

NLS Pharmaceutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-YA II PN, Ltd.(9.99%),YA Global Investments II (U.S.), LP(9.99%), etc.

Jan 12, 2022 05:52

NLS Pharmaceutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Oct 8, 2021 06:24

NLS Pharmaceutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Mar 18, 2021 04:10

NLS Pharmaceutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 4, 2021 19:30